Search - tctmd.com

Displaying 21 - 37 of 37

Sort: Relevancy | Date

News Conference News ISET 2017

Bioresorbable Scaffolds for PAD: Does the Strategy Have Legs?

Caitlin E. Cox

February 17, 2017

News Conference News ISET 2017

Targeted Delivery of Dexamethasone Combats Restenosis in Femoropopliteal Lesions: DANCE Trial

Caitlin E. Cox

February 15, 2017

News Conference News ISET 2017

Gains in Carotid Stenting Technology Could Increase the Treatment’s Appeal

Caitlin E. Cox

February 13, 2017

News Conference News ISET 2017

Percutaneous Bypass for Long, Complex SFA Lesions Holds Up Well to 6 Months: DETOUR I Study

Caitlin E. Cox

February 10, 2017

News Conference News ISET 2017

Patient Follow-up After Pulmonary Embolism Critical for Better Care, Understanding of Disease

Caitlin E. Cox

February 08, 2017

News Conference News ISET 2017

Positive 6-Month Outcomes Seen With Endovascular Therapy for Symptomatic PAD: LIBERTY 360

Caitlin E. Cox

February 07, 2017

News Conference News ISET 2017

Underappreciated by Clinicians, Critical Limb Ischemia Has Dire Fallout for Patients

Caitlin E. Cox

February 07, 2017

News Conference News ISET 2017

Forging Into the Future: Debating the Merits of TAVR in Younger, Futile, and Lower-Risk Patients

Caitlin E. Cox

February 06, 2017

News Conference News ISET 2016

Drug-Coated Balloon Angioplasty Superior for In-Stent Restenosis of SFA, but Results Leave Much To Be Desired

Michael O'Riordan

February 10, 2016

News Conference News ISET 2016

Aspiration Thrombectomy Restores Flow in Patients With Peripheral Arterial Occlusion: PRISM Registry

Michael O'Riordan

February 09, 2016

News Conference News ISET 2016

‘Encouraging’ Early Findings With Embolic Protection in TEVAR, Suggests Small Pilot Study

Michael O'Riordan

February 08, 2016

Presentation ISET 2015

Update on Peripheral Artery Stent Surveillance: Have We Learned Anything from Clinical Trials?

Presenter: Michael R. Jaff

January 31, 2015

Presentation ISET 2014

SMART™ Stent in the Treatment of Obstructive Superficial Femoral Artery Disease: Three-year Clinical Outcomes from the STROLL TRIAL

Presenter: Michael R. Jaff

January 20, 2014

Presentation ISET 2014

A Randomized Multicenter Clinical Trial of the Role of Renal Artery Stenting in Preventing Cardiovascular and Renal Endpoints: Results of the CORAL Study

Presenter: Christopher J. Cooper

January 20, 2014

Presentation ISET 2012

The Value of Dual Antiplatelet Therapy During and After Endovascular Procedures: Results of a Randomized Trial - The MIRROR Study

Presenter: Gunnar Tepe

January 17, 2012

Presentation ISET 2012

Clinical Experience with the TAVI: Update on the Partners Trial

Presenter: Ron Waksman

January 16, 2012

Presentation ISET 2012

LAA Closure: The Watchman Devices, Lessons Learned from the Clinical Trials

Presenter: Ramon Quesada

January 16, 2012

Advertisement

Bioresorbable Scaffolds for PAD: Does the Strategy Have Legs?

Targeted Delivery of Dexamethasone Combats Restenosis in Femoropopliteal Lesions: DANCE Trial

Gains in Carotid Stenting Technology Could Increase the Treatment’s Appeal

Percutaneous Bypass for Long, Complex SFA Lesions Holds Up Well to 6 Months: DETOUR I Study

Patient Follow-up After Pulmonary Embolism Critical for Better Care, Understanding of Disease

Positive 6-Month Outcomes Seen With Endovascular Therapy for Symptomatic PAD: LIBERTY 360

Underappreciated by Clinicians, Critical Limb Ischemia Has Dire Fallout for Patients

Forging Into the Future: Debating the Merits of TAVR in Younger, Futile, and Lower-Risk Patients

Drug-Coated Balloon Angioplasty Superior for In-Stent Restenosis of SFA, but Results Leave Much To Be Desired

Aspiration Thrombectomy Restores Flow in Patients With Peripheral Arterial Occlusion: PRISM Registry

‘Encouraging’ Early Findings With Embolic Protection in TEVAR, Suggests Small Pilot Study

Update on Peripheral Artery Stent Surveillance: Have We Learned Anything from Clinical Trials?

SMART™ Stent in the Treatment of Obstructive Superficial Femoral Artery Disease: Three-year Clinical Outcomes from the STROLL TRIAL

A Randomized Multicenter Clinical Trial of the Role of Renal Artery Stenting in Preventing Cardiovascular and Renal Endpoints: Results of the CORAL Study

The Value of Dual Antiplatelet Therapy During and After Endovascular Procedures: Results of a Randomized Trial - The MIRROR Study

Clinical Experience with the TAVI: Update on the Partners Trial

LAA Closure: The Watchman Devices, Lessons Learned from the Clinical Trials

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content